&noscript=1 />

Are You Eligible for a New Treatment for Advanced AMD?

Implantable Minature Teleschop: VisionCare Ophthalmic Technologies, Inc
VisionCare Ophthalmic Technologies, Inc

Take a brief eligibility survey to see if CentraSight®, a new treatment for advanced age-related macular degeneration (AMD), might be right for you. 

Three steps to take today:

  1. Call toll-free 1-855-539-0011
  2. Take a brief eligibility survey about a new treatment for advanced AMD
  3. Thanks to your phone call, CentraSight will donate $25 to Macular Degeneration Research

*Only one call per household

CentraSight, by VisionCare Ophthalmic Technologies, is a treatment program powered by the only FDA-approved telescope implant for advanced AMD. VisionCare is a proud corporate partner of BrightFocus' Macular Degeneration Research program. 

Please consult your physician for personalized medical advice. BrightFocus does not endorse any medical products or therapies. 

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.